RICHARD SEEBORG, District Judge.
Plaintiffs Amgen Inc. and Amgen Manufacturing, Limited ("Amgen") and Defendants Sandoz Inc., Sandoz International GmbH, Sandoz GmbH, and Lek Pharmaceuticals, d.d. ("Sandoz"), through their undersigned counsel, hereby stipulate and agree as follows:
WHEREAS, Sandoz filed bills of costs on January 22, 2018 (Case No. 3:14-cv-04741-RS, Dkt. No. 354; Case No. 3:16-cv-02581-RS, Dkt. Nos. 188, 191);
WHEREAS, counsel for both parties met and conferred regarding Sandoz's bills of costs and arrived at a compromise to avoid further burdening the Court;
WHEREAS, Sandoz agreed to reduce its requested costs for "Visual aids, Civil LR 54(d)(5)" in Case No. 3:14-cv-04741-RS (Dkt. No. 35) from $22,528.50 to $13,155.00;
WHEREAS, this adjustment reduces the total amount requested in Sandoz's bill of costs filed in Case No. 3:14-cv-04741-RS (Dkt. No. 35) from $145,141.49 to $135,767.99;
WHEREAS, the total amount requested in Sandoz's bill of costs filed in Case No. 3:16-cv-02581-RS (Dkt. Nos. 188, 191) remains unchanged at $915.00;
WHEREAS, in light of this reduction, Amgen agreed not to file objections or otherwise oppose Sandoz's bills of costs;
NOW, THEREFORE, the parties agree that costs in Case No. 3:14-cv-04741-RS may be taxed in the amount of $135,767.99 and costs in Case No. 3:16-cv-02581-RS may be taxed in the amount of $915.00.
Pursuant to Civil Local Rule 5-1(i)(3), I hereby certify that concurrence in the filing of this document has been obtained from each of the other Signatories shown above.